Qing Nian

547 total citations
30 papers, 351 citations indexed

About

Qing Nian is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Qing Nian has authored 30 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Immunology and 5 papers in Oncology. Recurrent topics in Qing Nian's work include Protein Tyrosine Phosphatases (6 papers), Galectins and Cancer Biology (4 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). Qing Nian is often cited by papers focused on Protein Tyrosine Phosphatases (6 papers), Galectins and Cancer Biology (4 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). Qing Nian collaborates with scholars based in China, France and Japan. Qing Nian's co-authors include Jinhao Zeng, Zhiqiang Zhang, Fernando Rodrigues‐Lima, Yuzhen Han, Li Wang, Maoyuan Zhao, Jérémy Berthelet, Qing Xiao, Lin Liu and Jing Luo and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and PLoS ONE.

In The Last Decade

Qing Nian

30 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qing Nian China 12 190 59 58 49 47 30 351
Mengli Gu China 10 153 0.8× 57 1.0× 27 0.5× 45 0.9× 47 1.0× 18 311
Jian Bi China 14 199 1.0× 50 0.8× 44 0.8× 53 1.1× 21 0.4× 26 505
Kolsoum Rezaie Kahkhaie Iran 6 202 1.1× 38 0.6× 37 0.6× 65 1.3× 58 1.2× 11 425
Liang-Mou Kuo Taiwan 10 135 0.7× 49 0.8× 101 1.7× 56 1.1× 64 1.4× 12 433
Xiyue Zhang China 9 181 1.0× 37 0.6× 27 0.5× 48 1.0× 42 0.9× 18 364
Ji‐Chao Zhou China 8 178 0.9× 34 0.6× 58 1.0× 33 0.7× 33 0.7× 15 381
Yuan Zhuang China 12 153 0.8× 29 0.5× 50 0.9× 50 1.0× 66 1.4× 43 366
Shufang Liang China 11 189 1.0× 34 0.6× 47 0.8× 96 2.0× 44 0.9× 17 313

Countries citing papers authored by Qing Nian

Since Specialization
Citations

This map shows the geographic impact of Qing Nian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Nian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Nian more than expected).

Fields of papers citing papers by Qing Nian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing Nian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Nian. The network helps show where Qing Nian may publish in the future.

Co-authorship network of co-authors of Qing Nian

This figure shows the co-authorship network connecting the top 25 collaborators of Qing Nian. A scholar is included among the top collaborators of Qing Nian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Nian. Qing Nian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nian, Qing, et al.. (2025). Targeting Myeloperoxidase in Disease Pathogenesis: Emerging Roles of Natural Products in Therapeutic Modulation. The American Journal of Chinese Medicine. 53(7). 1983–2019. 1 indexed citations
2.
Li, Meng, et al.. (2024). Circulating micronutrients levels and their association with the risk of endometriosis. Frontiers in Nutrition. 11. 1466126–1466126. 1 indexed citations
3.
Nian, Qing, et al.. (2024). Unraveling the pathogenesis of myelosuppression and therapeutic potential of natural products. Phytomedicine. 132. 155810–155810. 7 indexed citations
4.
Nian, Qing, et al.. (2024). Multifaceted functions of the Wilms tumor 1 protein: From its expression in various malignancies to targeted therapy. Translational Oncology. 52. 102237–102237. 2 indexed citations
5.
Zhang, Jin, et al.. (2024). Targeting neutrophil extracellular traps: A novel strategy in hematologic malignancies. Biomedicine & Pharmacotherapy. 173. 116334–116334. 5 indexed citations
6.
Nian, Qing, Yihui Li, Jingwei Li, et al.. (2023). U2AF1 in various neoplastic diseases and relevant targeted therapies for malignant cancers with complex mutations (Review). Oncology Reports. 51(1). 6 indexed citations
7.
Jiang, Tao, et al.. (2023). Role of Gut Microbiota and Oxidative Stress in the Progression of Transplant-Related Complications following Hematopoietic Stem Cell Transplantation. Oxidative Medicine and Cellular Longevity. 2023. 1–15. 7 indexed citations
8.
Hu, Qichao, Wenwen Zhang, Dan Song, et al.. (2023). Human diet‐derived polyphenolic compounds and hepatic diseases: From therapeutic mechanisms to clinical utilization. Phytotherapy Research. 38(1). 280–304. 13 indexed citations
9.
Pan, Huafeng, Maoyuan Zhao, Jundong Wang, et al.. (2023). Natural products for gastric carcinoma prevention and treatment: Focus on their antioxidant stress actions in the Correa's cascade. Phytomedicine. 123. 155253–155253. 9 indexed citations
10.
Feng, Wei, Qing Nian, Maoyuan Zhao, et al.. (2023). Natural products and mitochondrial allies in colorectal cancer therapy. Biomedicine & Pharmacotherapy. 167. 115473–115473. 14 indexed citations
11.
Han, Zhongyu, Hongli Liu, Jiong Zhang, et al.. (2022). A Deep Insight Into Regulatory T Cell Metabolism in Renal Disease: Facts and Perspectives. Frontiers in Immunology. 13. 826732–826732. 12 indexed citations
12.
Nian, Qing, Jingwei Li, Qi Liang, et al.. (2022). SPARC in hematologic malignancies and novel technique for hematological disease with its abnormal expression. Biomedicine & Pharmacotherapy. 153. 113519–113519. 7 indexed citations
13.
Zhao, Maoyuan, Guangwei Sun, Lu Zhan, et al.. (2022). Natural compounds targeting glycolysis as promising therapeutics for gastric cancer: A review. Frontiers in Pharmacology. 13. 1004383–1004383. 25 indexed citations
14.
Zeng, Jinhao, Lijuan Wen, Ting Xia, et al.. (2021). Assessment of clinical competency among TCM medical students using standardized patients of traditional Chinese medicine: A 5-year prospective randomized study. Integrative Medicine Research. 11(2). 100804–100804. 5 indexed citations
15.
Wu, Shi, et al.. (2021). Plant-Derived Compounds as Promising Therapeutics for Vitiligo. Frontiers in Pharmacology. 12. 685116–685116. 20 indexed citations
16.
Parlato, Marianna, Qing Nian, Fabienne Charbit‐Henrion, et al.. (2020). Loss-of-Function Mutation in PTPN2 Causes Aberrant Activation of JAK Signaling Via STAT and Very Early Onset Intestinal Inflammation. Gastroenterology. 159(5). 1968–1971.e4. 27 indexed citations
17.
Nian, Qing, Jérémy Berthelet, Wenchao Zhang, et al.. (2019). T-Cell Protein Tyrosine Phosphatase Is Irreversibly Inhibited by Etoposide-Quinone, a Reactive Metabolite of the Chemotherapy Drug Etoposide. Molecular Pharmacology. 96(2). 297–306. 10 indexed citations
18.
Nian, Qing, et al.. (2019). Ghrelin ameliorates A549 cell apoptosis caused by paraquat via p38-MAPK regulated mitochondrial apoptotic pathway. Toxicology. 426. 152267–152267. 33 indexed citations
19.
Duval, Romain, Linh‐Chi Bui, Cécile Mathieu, et al.. (2019). Benzoquinone, a leukemogenic metabolite of benzene, catalytically inhibits the protein tyrosine phosphatase PTPN2 and alters STAT1 signaling. Journal of Biological Chemistry. 294(33). 12483–12494. 19 indexed citations
20.
Nian, Qing, Qing Xiao, Li Wang, et al.. (2014). SPARC silencing inhibits the growth of acute myeloid leukemia transformed from myelodysplastic syndrome via induction of cell cycle arrest and apoptosis. International Journal of Molecular Medicine. 33(4). 856–862. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026